Baldero, Melisa E.
HRN: 23-48-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
CEFUROXIME 1.5GM (VIAL)
11/26/2023
11/28/2023
IV
1.5grams
Q8hrs X 3 Doses
Thickly MSAF; T/C IUFD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes